Alex Turnbull has joined a new diversity think-tank made up of senior leaders from the private sector patent and trade mark professionals. Together with other Firms, TLIP joined to ensure that diversity can be championed in the highest ranks, in partners’ meetings and boardrooms, to ensure it gets the recognition, and the hands-on support, that it deserves.
The European Patent Office announced this week that, from 4 January 2021, all examination and opposition hearings would be held via videoconference by default.
Liam Lawlor summaries the legal status of the European Unitary Patent System as it stands today.
UKIPO and EPO provide updates on extensions of time due to the coronavirus outbreak.
Following on from our News Article of 6 April 2020 “Personalised Medicine Patents at the EPO”, regarding a case law summary of the patent protection available for existing pharmaceuticals in terms of dosing regimens and specific patient groups, we now look to explore repurposing, repositioning and rescue (DRPx) of existing drugs and pharmaceuticals.
